Language: BG BG
nav.cta
← Back to results
Recruiting Phase 1 NCT07205289

Serum Collection Study for Assay Development

Phase 1 – testing safety in a small group of people
Conditions: Pneumococcal Disease, Invasive Pneumococcal Disease

Sponsor: GPN Vaccines

trial.available_in: БГ
Overview
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Description
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation Participants will receive a dose of Gamma-PN and serum will be collected pre dose and Day 28
Who can participate
Inclusion Criteria: * good general health Exclusion Criteria: * no previous pneumococcal vaccine
Locations 1
Australia (1)
University of Adelaide Clinical Research Facility
Adelaide , South Australia
Kirstee Smith
Technical details
Status
Recruiting
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Maximum age
69 Years
Healthy volunteers
No
Start date
01.10.2025
Completion date
01.06.2026
Registry ID
NCT07205289
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.